Pancreatic Cancer Drug Daraxonrasib
-
{
- All
- News
'Pancreatic Cancer Drug Daraxonrasib' - 1 News Result(s)
-
New Landmark Drug Nearly Doubles Survival In Advanced Pancreatic Cancer, FDA Approves
The US FDA has approved daraxonrasib, a targeted oral drug for previously treated metastatic pancreatic cancer. In a 500-patient trial, it nearly doubled median overall survival compared with standard chemotherapy
'Pancreatic Cancer Drug Daraxonrasib' - 1 News Result(s)
-
New Landmark Drug Nearly Doubles Survival In Advanced Pancreatic Cancer, FDA Approves
The US FDA has approved daraxonrasib, a targeted oral drug for previously treated metastatic pancreatic cancer. In a 500-patient trial, it nearly doubled median overall survival compared with standard chemotherapy
